Definitive Contract HHSN272201600024C
Award Date 8/11/16
Potential Completion Date 1/14/18
Potential Value $300K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Frederick, MD 21701, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
6
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
SBIR Program Phase I Action
Primary Consortia Member
Not listed Similar Awards
- This is a $224,978.00 firm fixed price contract awarded by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases to Akonni Biosystems Inc., a for-profit molecular diagnostics manufacturer. The contract is for sample preparation and screening of non-invasive pediatric specimens for lower respiratory disease, to be performed in Frederick, Maryland. The contract has a total small business set-aside designation. Akonni...
- This is a $2,999,954.00 Firm Fixed Price contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Akonni Biosystems Inc., a small business. The contract's purpose is to produce an inexpensive and easy-to-use sputum processing system for on-site molecular testing or transport to a centralized facility in a low-resource clinical setting. The contractor shall deliver a production-equivalent instrument and consumables compliant with CGMP and ISO...
- This is a SBIR Phase I contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the Department of Health and Human Services (HHS), to Nanocomposix, Inc., a small business manufacturer of engineered nanoparticles. The contract has a firm fixed price of $300,000.00 and is for the development of a point-of-care test to measure antibiotic concentrations in the blood for tuberculosis (TB) treatment. Nanocomposix has prior experience providing products...
- This is a fixed-price Small Business Innovation Research (SBIR) Phase I contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Pulmokine, Inc. for the development of "Aerosolized Delivery of Anti-Tubercular Drugs." The contract has a ceiling value of $224,960.00 and a period of performance ending on January 15, 2016. As an SBIR Phase I contract, this award supports early-stage research and...
- <p>This is a firm fixed-price contract awarded by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to B & W TEK Inc., a for-profit manufacturer, for Phase I of the Small Business Innovation Research (SBIR) Topic 073 project titled "Mobile Health Point-of-Care Diagnostics for Tuberculosis". The total contract value is $299,757, and the performance location is Newark, Delaware. The contract is set aside for small businesses.</p>
- This is a $1,486,937 definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to PAI Life Sciences Inc., a self-certified small disadvantaged business. The contract is for the development of an inhaled drug combination for tuberculosis therapy under the SBIR Phase II program. Key tasks include the manufacture of spray-dried combination drugs, technical support for pharmacokinetic and...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a Small Business Innovation Research (SBIR) Program Phase I contract to Northbound Therapeutics, Inc., a minority-owned, woman-owned small business, to develop an inhaled clofazimine powder as a novel treatment for multidrug-resistant tuberculosis (MDR-TB). The contract, valued at $37,500, is for the formulation and preclinical evaluation of the inhaled clofazimine powder. This SBIR contract is a Firm Fixed Price...
- The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the National Institutes of Health (NIH), awarded a $1,799,353.00 Small Business Innovation Research (SBIR) Program Phase I contract to Redbud Labs, Inc., a for-profit microfluidic chip manufacturer. The contract is a firm fixed price definitive contract to implement extraction compatibility with whole blood and tissue lysates, producing a portable and rapidly installable instrument that meets industry...
- The U.S. Department of Health and Human Services (HHS) National Institute of Allergy and Infectious Diseases (NIAID) awarded a $224,946 Small Business Innovation Research (SBIR) Phase I contract to Aerophase, Inc., a self-certified small disadvantaged business, for the "Treatment of Tuberculosis with Inhaled Delivery of Clofazimine." The contract is a firm-fixed-price definitive contract with a completion date of July 31, 2016. This contract supports research and development of an...
- The U.S. Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Diseases awarded a $299,999.00 Small Business Technology Transfer (STTR) Phase I contract to Guild Associates Inc., doing business as Guild Biosciences, a small business manufacturer of filtration, adsorption, and other products. The contract is for the development of an "Electrochemical Aptasensor for Anti-Tuberculosis Antibiotic Quantification". The contract...